Alkem Laboratories Limited Everolimus Export Data — India (DGFT 2022–2026)

Name: Alkem Laboratories Limited Everolimus Export Records India — #2 Exporter, 95 Shipments, $4.8M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Everolimus

India Pharmaceutical Trade Intelligence

$37.9M87 Suppliers67 CountriesHS 30049049

ExportsIndia → UNITED STATES50.5%India → GERMANY15.7%

ImportsSWITZERLAND → India$2.8M UNITED STATES → India$346.7K

#1 Supplier: NATCO PHARMA #1 Buyer: ASCEND GMBH

Alkem Laboratories Limited — Everolimus Exporter #2 | $5.2M Trade Value | TransData Nexus | TransData Nexus

Alkem Laboratories Limited — Everolimus Exporter Profile

Indian Pharmaceutical Exporter · #2 for Everolimus · $5.2M export value · DGFT Verified

Alkem Laboratories Limited is the #2 Indian exporter of Everolimus with $5.2M in export value and 95 verified shipments. Alkem Laboratories Limited holds a 12.5% market share in Everolimus exports across 4 countries. The company exports 30 pharmaceutical products worth $247.0M across 15 therapeutic categories.

Alkem Laboratories Limited — Everolimus Export Profile: Buyers & Destinations

Alkem Laboratories Limited Everolimus export treemap — buyers and destination countries | TransData Nexus

Where Does Alkem Laboratories Limited Export Everolimus?

Country	Value	Shipments	Share
UNITED STATES	$2.5M	80	80.4%
GERMANY	$489.1K	27	15.9%
CHILE	$81.5K	3	2.7%
AUSTRALIA	$31.5K	2	1.0%

Who Are the Top Buyers of Everolimus from Alkem Laboratories Limited?

Buyer	Country	Value	Orders
ASCEND LABORATORIES LLC	UNITED STATES	$1.1M	37
ASCEND LABORATORIES,LLC	UNITED STATES	$969.4K	27
ASCEND GMBH	GERMANY	$489.1K	27
ASCEND LABORATORIES, LLC	UNITED STATES	$167.1K	8
ASCEND LABORATORIESLLC	UNITED STATES	$117.5K	3
ASCEND LABORATORIES SPA	CHILE	$81.5K	3
ASCEND LABORATORIES,L,L,C,	UNITED STATES	$62.2K	3
ASCEND LABOATORIES LLC	UNITED STATES	$43.7K	1
PHARMACOR PTY LTD	AUSTRALIA	$31.5K	2
ASCEND LABORATORIES, LLC,	UNITED STATES	$29.1K	1

Alkem Laboratories Limited supplies Everolimus to 10 buyers globally. The largest buyer is ASCEND LABORATORIES LLC (UNITED STATES), followed by ASCEND LABORATORIES,LLC (UNITED STATES) and ASCEND GMBH (GERMANY). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Everolimus Formulations Does Alkem Laboratories Limited Export?

Product Description / Formulation	Value	Shipments
EVEROLIMUS TABLETS 0 5 MG 6X10S USA NDC NO 67877071931	$158.4K	4
PHARMACEUTICAL PRODUCTS : EVEROLIMUS TABLETS 0.5 MG 6X10'S USA NDC No67877071931	$120.8K	3
EVEROLIMUS TABLETS 1.0 MG 6X10S USA NDC	$120.5K	4
EVEROLIMUS TABLETS 0.75 MG 6X10S USA N	$118.7K	5
PHARMACEUTICAL PRODUCTS:EVEROLIMUS TABLE	$90.7K	4
EVEROLIMUS TABLETS 0.5 MG 6X10S USA ND	$82.1K	2
PHARMACEUTICAL PRODUCTS: EVEROLIMUS TABL	$77.6K	2
PHARMACEUTICAL PRODUCTS EVEROLIMUS TABLE	$71.3K	2
PHARMACEUTICAL PRODUCTS EVEROLIMUSTABLETS 0.5 MG 6X10'S USA NDC NO67877071931	$68.0K	2
EVEROLIMUS TABLETS 0.5 MG 6X10S USA NDC NO. 67877071931 .	$63.6K	2

Alkem Laboratories Limited exports 81 distinct Everolimus formulations including tablets, capsules, syrups, and combination drugs. The top formulation is EVEROLIMUS TABLETS 0 5 MG 6X10S USA NDC NO 67877071931 with 4 shipments worth $158.4K.

How Does Alkem Laboratories Limited Compare to Nearest Everolimus Exporters?

Exporters ranked immediately above and below #2 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
1	NATCO PHARMA LIMITED	$11.2M	223	8	$50.0K
2	ALKEM LABORATORIES LIMITED ★	$4.8M	95	4	$50.0K
4	BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED	$750.0K	15	8	$50.0K
6	ALKEM LABORATORIES LTD	$464.8K	17	2	$27.3K

Alkem Laboratories Limited ranks #2 among 87 Indian Everolimus exporters. Average shipment value of $50.0K compared to the market average of $205.9K. The closest competitors by value are NATCO PHARMA LIMITED and BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED.

Which Indian Ports Ship Everolimus Exports?

Port	Shipments	% Share
SAHAR AIR CARGO ACC (INBOM4)	91	14.7%
HYDERABAD AIR	91	14.7%
SAHAR AIR	79	12.7%
HYDERABAD ACC (INHYD4)	61	9.8%
DELHI AIR	43	6.9%
NHAVA SHEVA SEA (INNSA1)	29	4.7%
ACC SHAMSHABAD AIRPO	23	3.7%
Bombay Air	20	3.2%

Geopolitical & Trade Policy Impact on Alkem Laboratories Limited's Everolimus Exports

The current geopolitical climate presents both challenges and opportunities for Indian pharmaceutical exporters like Alkem Laboratories. Escalating tensions in the Red Sea region, particularly due to Houthi attacks, have disrupted traditional shipping routes, leading to increased freight costs and extended delivery timelines. Major carriers have rerouted vessels around the Cape of Good Hope, adding 10–20 days to transit times and raising freight rates by 40–50% on key India–Europe routes (livemint.com). This logistical upheaval necessitates strategic adjustments in supply chain management to mitigate delays and cost escalations.

Conversely, the ongoing US-China trade tensions have prompted the United States to diversify its pharmaceutical supply sources, potentially benefiting Indian exporters. Alkem's established presence in the US market positions it to capitalize on this shift, provided it maintains stringent compliance with US regulatory standards. Additionally, the recent India–European Union Free Trade Agreement, signed in January 2026, aims to eliminate tariffs on pharmaceuticals, enhancing the competitiveness of Indian exporters in the EU market (en.wikipedia.org). However, compliance with the EU's Falsified Medicines Directive remains imperative to ensure market access.

Alkem Laboratories Limited — Regulatory Compliance & Quality Standards

Regulatory compliance is paramount for sustaining export operations in stringent markets like the US and EU. Alkem's subsidiary, Enzene Biosciences, recently underwent a USFDA inspection at its Chakan facility, resulting in six procedural observations but no data integrity issues (m.economictimes.com). This outcome underscores the company's commitment to quality assurance and regulatory adherence. Continuous investment in compliance infrastructure and proactive engagement with regulatory bodies are essential for Alkem to navigate the evolving global regulatory landscape effectively.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Everolimus shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Alkem Laboratories Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 112 individual customs records matching Alkem Laboratories Limited exporting Everolimus, covering 81 formulations to 4 countries via 10 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 67+ countries, 135+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Everolimus

Everolimus

Alkem Laboratories Limited — Everolimus Exporter Profile

Alkem Laboratories Limited — Everolimus Export Profile: Buyers & Destinations

Where Does Alkem Laboratories Limited Export Everolimus?

Who Are the Top Buyers of Everolimus from Alkem Laboratories Limited?

What Is India's Total Everolimus Export Value and How Much Does Alkem Laboratories Limited Contribute?

What Is the Average Shipment Value for Alkem Laboratories Limited's Everolimus Exports?

How Does Alkem Laboratories Limited Compare to Other Indian Everolimus Exporters?

What Everolimus Formulations Does Alkem Laboratories Limited Export?

Regulatory Requirements: Exporting Everolimus to Key Markets

United States — FDA

Germany — BfArM/EMA

How Does Alkem Laboratories Limited Compare to Nearest Everolimus Exporters?

Which Indian Ports Ship Everolimus Exports?

What Other Immunosuppressants Products Does Alkem Laboratories Limited Export?

Geopolitical & Trade Policy Impact on Alkem Laboratories Limited's Everolimus Exports

Alkem Laboratories Limited — Regulatory Compliance & Quality Standards

About Alkem Laboratories Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Everolimus Export Data from Alkem Laboratories Limited

Everolimus Stats

Company Overview

Top Products by Alkem Laboratories Limited

Related Analysis

Need Detailed Export Data?

Data Source